BDF Gestion Sells 3,844 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

BDF Gestion lessened its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 11.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 29,592 shares of the medical device company’s stock after selling 3,844 shares during the period. BDF Gestion’s holdings in Cooper Companies were worth $2,720,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Victory Capital Management Inc. grew its holdings in shares of Cooper Companies by 23.0% during the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after buying an additional 737,726 shares during the last quarter. Franklin Resources Inc. grew its holdings in shares of Cooper Companies by 194.0% during the third quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company’s stock valued at $5,265,000 after buying an additional 32,260 shares during the last quarter. Principal Financial Group Inc. grew its holdings in shares of Cooper Companies by 6.6% during the third quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company’s stock valued at $26,295,000 after buying an additional 14,687 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Cooper Companies by 13.2% during the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock valued at $543,979,000 after buying an additional 573,908 shares during the last quarter. Finally, Bank of Montreal Can grew its holdings in shares of Cooper Companies by 51.4% during the third quarter. Bank of Montreal Can now owns 326,520 shares of the medical device company’s stock valued at $35,845,000 after buying an additional 110,878 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of Cooper Companies stock opened at $98.00 on Thursday. The Cooper Companies, Inc. has a 52-week low of $84.76 and a 52-week high of $112.38. The stock has a market capitalization of $19.56 billion, a price-to-earnings ratio of 50.26, a price-to-earnings-growth ratio of 2.41 and a beta of 0.99. The company has a fifty day moving average of $95.91 and a 200-day moving average of $99.54. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same period in the prior year, the business posted $0.87 EPS. The firm’s revenue was up 9.8% compared to the same quarter last year. Equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. Wells Fargo & Company boosted their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Citigroup cut their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a report on Friday, December 6th. Morgan Stanley cut their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Four investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat, Cooper Companies has an average rating of “Moderate Buy” and a consensus price target of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.